The Seoul International New Pharmaceuticals Forum, which took its first step in 2009, celebrates
its 10th anniversary this year.
The Seoul International New Pharmaceuticals Forum, which has been launched under the theme
of "Beyond the Barrier of the Global New Pharmaceuticals" at the first Forum, has been dealing the
major issues emerging in the development of new pharmaceuticals every year, such as △ Changes
and challenges in the new pharmaceuticals development paradigm △ A new 10-year for
Pharmaceutical and Bio fields △ Global innovative new pharmaceuticals - Customized medicines
△ Creative economy era and R & D for new pharmaceuticals △ Creative paradigm of pharmaceutical
industry: Establishment of a virtuous cycle structure for the development of new pharmaceuticals
△ Research of new diseases due to bacteria and virus, development of therapeutic medicines and
vaccines to control them △ Pharmaceutical industry, prior occupation of new market for therapeutic
medicines to control rare diseases as a new growth engine and △ Development of new pharmaceuticals
using medical big data.
In the meantime, the pharmaceutical industry has undergone drastic changes. In particular, domestic
pharmaceutical companies have been making continuous efforts to develop new pharmaceuticals.
As a result, exports of complete products of pharmaceuticals surpassed $ 2 billion for the first time
last year. This was achieved in four years after the export volume exceeded $ 1 billion in 2013. In
addition, the exports of bio-pharmaceuticals, which have just entered the market, recorded over
$1 billion in 2016.
Of course, there was a sharp decline in sales in 2010 due to the implementation of the bilateral
punishment against rebate payment. However, large domestic pharmaceutical companies, including
Hanmi Pharm. Company, have concluded contracts for technology exportation with global Big-Pharma.
companies one after another, enhancing the possibility of new pharmaceutical development.
In response to this trend, the Government, at the Pharmaceutical Industry Promotion Committee
early this year, has disclosed that it will provide the implementation plan for detailed projects for the
development of new pharmaceuticals using information and communication technology (ICT) and
the development of next-generation bio-pharmaceuticals such as the medicines for l dementia and
gene therapy in order take lead in the 4th industrial revolution.
At the Seoul International New Pharmaceuticals Forum this year, you can find out how Open
Innovation, a new conception emerging at the backdrop of the 4th industrial revolution, shall be
applied to the development of new pharmaceuticals. Currently, there are cases where the results
have reached clinical level through the inter-country projects with Duke University and University
In addition, IBM will present a review on how you can use AI, the core technology of the 4th industrial
revolution, in R & D for new pharmaceuticals development. Further, you will be furnished with
updated information about CAR-T of Novartis, the personally customized cell therapy medicine,
that has emerged as a new issue recently, as well as AstraZeneca's 5R framework aimed to improve
the productivity of new pharmaceuticals development researches.
The 10th Seoul International New Pharmaceuticals Forum will have the opportunity to examine
how new technologies developing in the path of 4th industrial revolution, can help develop new
pharmaceuticals through its application to such development projects.
Title : The 10h Seoul International New Pharmaceuticals Forum
Theme : New Drug Development, Convergence with New Technology
Date : June 21st, 2018(Thu) / 09:00 ~ 16:00
Venue : Grand Ballroom, The Westin Chosun Hotel, Seoul
Host : The Financial News, Korea Research Institute of Chemical Technology
Supporters : Ministry of Health and Welfare, Ministry of Science and ICT,
National Institute of Food and Drug Safety Evaluation,
Korea Pharmaceutical and Bio-Pharma Manufacturers Association,
Korea Biotechnology Industry Organization,
Korea Research-based Pharmaceutical Industry Association
Inquiry : Seoul International New Pharmaceuticals Forum
Tel. 02-6965-0014 / Mail. firstname.lastname@example.org